Diametric Capital »

Inovio Pharmaceuticals shares owned by Diametric Capital

Quarter-by-quarter ownership of Inovio Pharmaceuticals (INO) shares owned by Diametric Capital from 13F filings

Historical chart of Diametric Capital investment in Inovio Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inovio Pharmaceuticals held by Diametric Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inovio Pharmaceuticals by Diametric Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $43k 25k 1.74

More positions owned by Diametric Capital

Precigen (PGEN)
Bitmine Immersion Tecnologie Com New (BMNR)
Janone (ALTS)
Liquidia Corporation Com New (LQDA)
Fulgent Genetics (FLGT)
Golar Lng SHS (GLNG)
Penn National Gaming (PENN)
Wynn Resorts (WYNN)
Brinker International (EAT)
Forgent Power Solutions Com Shs Cl A (FPS)
Asp Isotopes (ASPI)
Telephone & Data Sys Com New (TDS)
Harrow Health (HROW)
Eton Pharmaceuticals (ETON)
A2z Cust2mate Solutions Corp (AZ)

View all positions for Diametric Capital

Top funds holding Inovio Pharmaceuticals

FMR
Vanguard Group
Henderson Group
Vanguard Capital Management
Adage Capital Partners GP
Boxer Capital Management
D. E. Shaw & Co
ADAR1 Capital Management
Millennium Management
Geode Capital Management
BlackRock
Diadema Partners
Renaissance Technologies
Citadel Advisors
Vanguard Fiduciary Trust

View all funds holding Inovio Pharmaceuticals